Tivic Health (TIVC, Financial) has successfully wrapped up all study visits for its Optimization Study focused on a non-invasive device that stimulates the cervical vagus nerve. This research was carried out by The Feinstein Institute of Bioelectronic Medicine. The primary goal was to determine the best parameters for the device to positively impact the autonomic nervous system's function.
The company anticipates sharing the study findings later this year. These insights will be crucial in preparing for a forthcoming Phase I clinical trial, which will further evaluate the device's effectiveness.
